register

News & Trends - Pharmaceuticals

Pharmacy Guild supports real time monitoring of opioids

Health Industry Hub | February 10, 2020 |

The Pharmacy Guild of Australia welcomes the renewed push by Health Minister, Greg Hunt, to achieve a national system of real time opioid prescription monitoring by the end of 2020.

The Pharmacy Guild has long supported and called for the introduction of national real time recording of controlled drugs, a move which will benefit vulnerable patients and provide significant clinical decision-making support for doctors and pharmacists.

A national, uniform real-time monitoring system, will enable pharmacists to identify and support patients at risk of dependence and will also help to counter doctor shopping.

National President of the Pharmacy Guild of Australia, George Tambassis said: “We wholeheartedly welcome Minister Hunt’s declaration that real time recording across Australia is a matter of priority.

“Some States and Territories have already developed systems, but we need all jurisdictions on board and systems that talk to each other to ensure a nationally effective approach,” said Mr Tambassis.

“Victoria’s Safescript is evidence of the effectiveness of real time monitoring in reducing high-risk opioid doses. As a result of this program, high-risk opioid doses is reported to have decreased 25 per cent between April and October last year,” he said.

“Community pharmacists and the Guild stand ready to work with State and Territory Governments to make this a reality as soon as possible. We have to get this done,” Mr Tambassis said.

Enhance corporate branding and boost thought leadership to attract and retain quality employees. Health Industry Hub is the only one-stop-hub connecting Australia’s Pharma, MedTech, and Biotech industry professionals. Get started with our proven digital media solutions developed by industry for industry.

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

You may also like New PBS listings to bring hope for Australians living with kidney disease, cystic fibrosis and cancer


Digital & Innovation

Meta finally admits to exploiting Aussie data for AI training: Call for privacy law reforms

Meta finally admits to exploiting Aussie data for AI training: Call for privacy law reforms

Health Industry Hub | September 13, 2024 |

Digital & Innovation: Facebook uses photos, posts and data from its adult Australian users to train AI models, Meta’s global […]

More


News & Trends - MedTech & Diagnostics

Policymakers undergo diabetes health check as push for equitable access to medical technologies escalates

Policymakers undergo diabetes health check as push for equitable access to medical technologies escalates

Health Industry Hub | September 13, 2024 |

MedTech News: Policymakers at Parliament House underwent a comprehensive health check yesterday, including assessments for HbA1c, cholesterol, blood pressure, and […]

More


News & Trends - Pharmaceuticals

Diabetes drugs underused in Australia despite proven benefits, study reveals

Diabetes drugs underused in Australia despite proven benefits, study reveals

Health Industry Hub | September 13, 2024 |

Pharma News: A new analysis has revealed that more Australians with type 2 diabetes should have access to potentially lifesaving […]

More


News & Trends - MedTech & Diagnostics

Landmark funding to expand genomic testing and precision medicine access for Victorian cancer patients

Landmark funding to expand genomic testing and precision medicine access for Victorian cancer patients

Health Industry Hub | September 13, 2024 |

Diagnostics News: A landmark funding contribution will establish an advanced genomic testing program in Victoria, aiming to deliver personalised, precision […]

More


This content is copyright protected. Please subscribe to gain access.